Pharvaris (PHVS) Interest Coverage Ratio (2020 - 2024)

Pharvaris' (PHVS) quarterly Interest Coverage Ratio came in at 0.0 in Q3 2024, down 99.97% on a QoQ basis from 1.0 in Q4 2023.

Pharvaris (PHVS) Interest Coverage Ratio (2020 - 2024) Analysis & Trends

Pharvaris (PHVS) has 5 years of Interest Coverage Ratio data on file, last reported at 0.0 in Q3 2024.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 241.5 (down 100.0% YoY) and the FY2023 annual result came in at 0.0, up 100.0% from the prior year.
Interest Coverage Ratio eased to 0.0 in Q3 2024, from 1.0 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 1149.68 in Q4 2022 to a low of 1453.56 in Q4 2021.
A 5-year average of 65.76 and a median of 25.8 in 2021 frame the typical range for Interest Coverage Ratio.
The widest YoY moves for Interest Coverage Ratio: up 184.09% in 2022, down 407.76% in 2022.
Tracing PHVS's Interest Coverage Ratio over 5 years: stood at 135.02 in 2020, then sank by 976.57% to 1453.56 in 2021, then surged by 179.09% to 1149.68 in 2022, then sank by 99.91% to 1.0 in 2023, then sank by 99.97% to 0.0 in 2024.
The last three Interest Coverage Ratio figures came in at 0.0 (Q3 2024), 1.0 (Q4 2023), and 1149.68 (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Pharvaris	2.29 Bn	1.92 Bn	-	-

Download Data